Brief: Quantum Genomics Enters Into Exclusive Agreement With Xediton Pharmaceuticals
28/10/2020 06:05
Oct 28 (Reuters) - QUANTUM GENOMICS SA ALQGC.PA :
* TO RECEIVE UP TO $11.35 MILLION IN UPFRONT AND MILESTONE
PAYMENTS PLUS DOUBLE-DIGIT ROYALTIES ON SALES
* ENTERS INTO EXCLUSIVE LICENSING AND COLLABORATION
AGREEMENT WITH
XEDITON PHARMACEUTICALS
Source text for Eikon: ID:nGNXbbhTT5
Further company coverage: ALQGC.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Quantum Genomics SA
See all newsBrief: Quantum Genomics Announces Resumption Of Discussions With HealthTech, Terminates Exclusive Negotiations With Vistacare Medical
Brief: Quantum Genomics Enters Into Exclusive Negotiations With Vistacare Medical
Brief: Quantum Genomics To Reduce Staff; Jean-Philippe Milon Becomes President and CEO
Brief: Quantum Genomics In Talks For New Strategic Project
Brief: Quantum Genomics Announces Lack Of Significant Efficacy For Firibastat In Their Phase Iii Study